home > research channels > sectors > pharma > reports

Reports Archive   Year   
Date Title Pages Source Download
Sep-19 The China Opportunity, US pricing has stabilized   30 Nirmal Bang
Aug-19 Recovery visible; price growth impressive   28 Motilal Oswal
Aug-19 US growth, margin improvement drive Q1...   15 ICICI direct.com
Aug-19 Healthy performance amid challenges   10 Edelweiss Securities
Aug-19 Returns to double-digit growth but sustenance remains the key   17 Emkay Research
Jul-19 India Pharma: Q1 preview   11 Anand Rathi
Jul-19 IPM growth remains weak at 8.8% in June 2019   17 Emkay Research
Jul-19 US growth, consolidation to drive Q1 numbers...   11 ICICI direct.com
Jul-19 Stable Quarter aided by weak base   9 Centrum Research
Jul-19 Recovery still out of sight   14 Emkay Research
Jul-19 1QFY20E Results Preview   13 HDFC Securities
Jul-19 Strong results puffed by one-offs   11 Edelweiss Securities
Jul-19 Strong growth on favourable base   9 Edelweiss Securities
Jun-19 Upbeat Q4 numbers; warning letter to Aurobindo...   15 ICICI direct.com
Jun-19 Prescription Trends – Notable Changes   9 Nirmal Bang
Jun-19 IPM growth slows down to 8.6% in May 2019   16 Emkay Research
Jun-19 Domestic market promises good growth   12 Centrum Research
Jun-19 Earnings cuts continue   10 Edelweiss Securities
May-19 India Pharma: quality perception issues   6 IIFL
May-19 Generic onslaught on the branded domestic space   17 Edelweiss Securities
May-19 US regulatory issues persist   14 HDFC Securities
Apr-19 US led by one-offs; India remains stable   9 IIFL
Apr-19 Ind AS 116: Impact analysis on Healthcare companies   7 Edelweiss Securities
Apr-19 Steady overall growth, volumes yet to pick up   24 Motilal Oswal
Apr-19 4QFY19E Results Preview   11 HDFC Securities
Apr-19 US Business To Aid Performance   4 Nirmal Bang
Apr-19 Hyderabad Visit Note   27 Prabhudas Lilladher
Apr-19 A story of two halves   11 Edelweiss Securities
Apr-19 Growth muted on prolonged winter   9 Edelweiss Securities
Mar-19 Prescription Trends - New Launches   8 Nirmal Bang
Mar-19 Generic onslaught on the branded domestic space   17 Edelweiss Securities
Feb-19 Strong Q3 numbers; beat on all fronts   19 ICICI direct.com
Feb-19 Soft numbers; valuation favourable   16 Edelweiss Securities
Jan-19 Prescription Trends – Notable Changes   7 Nirmal Bang
Jan-19 IPM growth picks up led by prices, volume growth stable   22 Motilal Oswal
Jan-19 India Pharma: Q3 preview - Expect muted earnings   11 Edelweiss Securities
Jan-19 3QFY19E Results Preview   11 HDFC Securities
Jan-19 Strong show likely on a weak base   12 Edelweiss Securities
Jan-19 December 2018 Quarter Result Preview   3 Nirmal Bang